Santen Pharmaceutical News and Activities

Presence

Santen Pharmaceutical develops and sells prescription and consumer eye care products, including treatments for glaucoma, dry eye, and allergies. It serves patients, eye care professionals, hospitals, and pharmacies.

Santen Pharmaceutical products and services overview:

Prescription eye drugs
Consumer eye care
Dry eye treatments
Glaucoma treatments
Allergy eye treatments
Surgical ophthalmic products

Revenue: ~$2 billion

Employees: 4,000

Headquarters: Osaka, Japan

Santen Pharmaceutical is one of the...

Santen Pharmaceutical is a company listed under the stock ticker 4536 (JP).

Santen Pharmaceutical has a direct presence in 4 countries.

Santen Pharmaceutical has 3 subsidiaries including Santen Pharma EMEA, Santen Pharma Iberia and Santen Pharma USA.

Executives

View the org chart displaying its 40 main executives

Most searched biographies at Santen Pharmaceutical

Popular executive movements at Santen Pharmaceutical

Yoko Saiki, who was Global Head of Corporate Strategy, is promoted to Chief Human Resources Officer (posted on October 9 2025).
Mark Dawson, Chief Product Supply Officer, has left the company (posted on October 2 2025).
Frank Binder, Executive Officer, Chief Director of Supply Chain, has left the company (posted on October 2 2025).

Create your alert
to follow the executive moves at Santen Pharmaceutical.